Division of Hematology and Oncology | Department of Internal Medicine | UC Davis Health

Integrated with the UC Davis Comprehensive Cancer Center, our division brings together hematologists and oncologists. Many blood disorders are benign, but nearly half of the blood disorders we encounter are malignant (cancerous). We are at the forefront of research and treatment. We have firsthand experience in encountering and managing a wide variety of conditions. That results in timely, accurate diagnoses and pinpoint novel treatments. Our clinicians are part of the team that introduced FDA-approved Chimeric Antigen Receptor T-cell therapy (CAR T-cell) to the Sacramento region. CAR T-cell therapy is a new immunotherapy approach that has been effective for lymphoma patients who are not responsive to chemotherapy and cannot undergo a stem cell transplant. Our researchers are advancing the application of regenerative medicine as well, and we’re training future hematologists and oncologists.